NCT06958809View on ClinicalTrials.gov

Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 1, 2026

Primary Completion Date

July 1, 2027

Study Completion Date

August 1, 2027

Conditions
Septic ShockFluid ResuscitationCongestion, Venous
Interventions
DIAGNOSTIC_TEST

Echography

An exhaustive echography will be performed to determine fluid responsiveness (using a passive leg raising test and cardiac output measurement by left ventricular outflow tract velocity time integral)

Trial Locations (1)

92100

Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris,, Boulogne-Billancourt

All Listed Sponsors
lead

Hospital Ambroise Paré Paris

OTHER

NCT06958809 - Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients | Biotech Hunter | Biotech Hunter